the exclusive rights to Entos Pharmaceuticals' proprietary Fusogenix nucleic acid delivery technology platform to develop and commercialize drugs targeting the central and peripheral nervous systems. Nucleic acid therapy
Soybean imports fell by 40% in October, soybean meal fell 450 yuan/ton, cotton meal fell 350 yuan/ton, Henan Feed
Time of Update: 2021-11-13
Soybean imports fell to the lowest level in 7 monthsTtv China Feed Industry Information Network-Based on feed, serving animal
Over 450 million US dollars: Hausen introduces siRNA therapy for liver disease
Time of Update: 2021-10-21
As part of the cooperation agreement, the two companies will use OliX Pharmaceuticals’ GalNAc-asiRNA platform and Hansen Pharmaceuticals’ strong R&D, production and commercialization capabilities in China to develop multiple hepatocyte-targeted products, involving Areas include cardiovascular, metabolic and other indications .
In 2016, the output value of coatings will reach 450 billion yuan
Time of Update: 2021-08-01
Sun Lianying, President of China Coatings Industry Association, pointed out at the meeting that the total output of my country's coatings will reach 18 million tons in 2016.
New Sharp | Technolab completes 450 million yuan A round of financing, Hillhouse Ventures leads the investment
Time of Update: 2021-05-09
/> This financing was led by Hillhouse Ventures, and Kangzhe Pharmaceutical, Wuxi Bio-Industry Fund, Wuxi League of Nations, etc. jointly participated in the completion. > Technolab was established
Industry Weekly's gene editing company has made progress in financing 450 million 39 drug consistency evaluations
Time of Update: 2020-11-01
doctor once all users have registered, without an appointment. 98point6's platform-specific applications are available on both Android, iOS, and PC side, and provide health management solutions for individuals, families (including families 1
With the completion of the 450 million yuan B round of financing, Boya will continue to promote the clinical transformation of gene editing technology.
Time of Update: 2020-10-22
development. , Boya has established a clinical conversion application base in Nansha District, Guangzhou, in 2018 that meets GMP standards. about EdiGene, Inc. is a biopharmaceutical company dedicated to accelerating drug research and developing
23-year-old trading 40 billion pharmaceutical companies, now a surge of 450%, holding a billion pharmaceutical empire!
Time of Update: 2020-06-25
Guide: Who says rich is no more than three generations? there is an old Chinese saying that "rich but three generations", many family businesses in the first generation set a peak, to the second generation, the third generation, began
Pharmaceutical stocks a brother impact 450 billion market value, Kantai, Meirui soared by more than 50%!
Time of Update: 2020-05-28
Pharmaceutical Network May 26, 2017 in the A-share market, there have been Hengrui Pharmaceuticals, Kangmei Pharmaceuticals, Yunnan White Medicine, Shanghai Laishi and other 600 billion market value of pharmaceutical stocks in the peak period
450 million! The first domestic bio similar drug was approved for market
Time of Update: 2019-02-27
On February 22, the State Drug Administration approved the listing registration application of rituximab injection (trade name: hanlikang) developed by Shanghai Fuhong Hanlin
Yaoming biological Co., Ltd. is authorized to use wuxibody (TM) to develop five double antibodies with us $450 million
Time of Update: 2018-12-11
December 11, 2018 / Meitong news agency / -- Wuxi biology, the world's leading open biopharmaceutical technology platform company, 2269
HK) announced today
Health care product registration open! 450 billion market, cross-border pharmaceutical enterprises
Time of Update: 2016-09-07
Source: on July 1, 2016, the administrative measures for registration and filing of health food was officially implemented in Beijing News
The management mode of health
Baiji Shenzhou completed the financing of 450 million yuan for three phase I clinical trials of anticancer drugs
Time of Update: 2014-11-15
This round of funds comes from the original angel and strategic investors as well as new investors: Hillhouse capital, the US dollar fund of CITIC Industrial Fund and a blue chip
Roche acquires Danish pharmaceutical company Santaris Pharma for USD 450 million
Time of Update: 2014-08-06
According to the agreement signed by both parties, Roche will pay 250 million US dollars in advance and 200 million US dollars in the balance after the products reach the expected target.
Roche acquires Danish pharmaceutical company Santaris Pharma for USD 450 million
Time of Update: 2014-08-06
According to the agreement signed by both parties, Roche will pay 250 million US dollars in advance and 200 million US dollars in the balance after the products reach the expected target.
Pharmaceutical giant Eli Lilly has been fined $450 million for pollution in Brazil
Time of Update: 2014-05-12
Source: the growing environmental pressure of Beijing Business Daily on May 12, 2014 is a headache for pharmaceutical companies
A local labor court in Brazil has fined
Roche's $450 million acquisition of iquum to enter the market of molecular diagnosis POC
Time of Update: 2014-04-08
Roche will obtain iqum's Liat system (laboratory in-a-tube), which enables nurses to carry out rapid molecular diagnosis tests in closer proximity to the patient's nursing site with minimal training.
